Tuesday next week, not Friday.

First 249 Last

Share
Profile

Follow
fatbuuoy

275 Posts.

96

21/04/22

10:35

Post #: 60948650
Share

Originally posted by pilko3: ↑

Ports that is not very detailed an outline of an alternative offer IMHO and with respect. It is difficult when assessing a deal or offer to make a call without these details plus the latest as well as projected earnings (from existing partners to be fair) for 12 months at least. This is why IMHO a fair value assessment MUST INCLUDE the latest RAP revenue figures plus some future projections. Otherwise we are in the dark and are being undervalued...after all the point is to reach a fair value. If we don't want to sell at 11.5 cents then (as you say) what will we "give in" at? Many here including LT holders would drop their pants for 30 cents or 40 cents. They most likely bought in at sub 5 cents.
So my two questions are
1...In the case of a counter offer would Pfizer match it? If this offer is say 23 cents then we can see that Pfizer are trying to steal the company.
2...if another bidder arrives at 23 cents and they are happy to swap shares and cash for equity do we vote YES? We actually can't say can we? The whole deal is postulation and obscure so we sit and await the quarterly revenues and hold our position.

At this stage it is no from us so that is where it sits...any move by us or any other party is going to depend on the revenues and our refusal to accept the Pfizer Paltry Offer...PPO! 8 days to go...Friday next week we see how the vibe is from our current leader TK...don't forget he is hard to read and as conservative as they come and sniffs fame and fortune possibly coming his way. That is a big driver. It overrides loyalty and integrity more often than not. Big test for TK coming up IMHO...watch and listen to what is said carefully! Our next move/s are obscure at this stage...but the Universe is with us!

Expand

Tuesday next week, not Friday.

RAP Price at posting: 11.3¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel